Lumis Life Science Consulting GmbH (Lumis) is specialized to support small and mid-sized medical device and biopharmaceutical companies during their clinical drug development. Their services cover the whole spectrum of regulatory consulting for preparation and conduct of scientific advice meetings, implementation of clinical trials through vendor selection and management and clinical trial oversight management. Quality management as a service includes the analysis and establish complete quality management systems to enhance their customers’ inspection readiness. Jointly with their customers, they develop tailored solutions to optimise their clinical product development programs.
Lumis collaborates with a network of experienced subject matter experts, cooperation partners and consultants to offer best practises in the different service fields supporting the core team at Lumis.. Flexibility and empathy are core to the Lumis brand. The customers of Lumis are organisations at all different sizes ranging from small virtual clinical stage start-up companies to late-stage clinical trial companies.
How else can Lumis support with respect to Clinical Trials?
It is the goal of Lumis to advance the most suitable development strategy for your specific clinical projects. Through a joint decision-making approach, they generate a CRO and vendor selection process customised to your expectations, your resources and your goals. Guided by the Lumis experts, you will find the right balance between outsourcing, insourcing and your budget.
- Regulatory Consulting
- Clinical Outsourcing strategy
- Vendor Selection &Vendor Management
- Clinical trial Oversight Management (ICH GCP E6 (R2))
- Quality Management systems and tools
- Sponsor-Vendor Conflict resolution
- Translation from preclinical to clinical development
About Clinical Trials Innovation Programme 2022
Clinical Trials Innovation Programme is an invitation-only, premium event bringing together a mix of clinical research professionals and service providers in one stimulating environment.
Join us face to face to learn from the best in the drug development industry and have an opportunity to learn from their experiences. With an agenda covering the future of Clinical trials and drug development post COVID, Clinical Trials Innovation Programme 2022 will feature tailored sessions presented by the leading experts from across the globe.
We are bringing together the best in the industry to help you learn and grow, and accelerate your drug development journey. The experts will include thought leaders and visionaries from Danish Medicines Agency, Bayer Pharmaceuticals, AstraZeneca The Janssen Pharmaceutical Companies of Johnson & Johnson, Travere Therapeutics, Biogen, Vifor Pharma, Medical Products Agency and much more.